Efficacy of antiplatelets in deep venous thrombosis

Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

The challenges of implementing the VAD Act

As the date for implementation of the Voluntary Assisted Dying (VAD) Act moves closer, the development of clinical practices around the law is underway....

New alliance between PSA and SHPA announced

At PSA19 this morning, it was revealed that a Memorandum of Understanding (MoU) was signed by PSA and the Society of Hospital Pharmacists of...

Pondering aged care

After starting my pharmacy career working in a neonatal intensive care unit, tending to the pharmacy needs of premature babies, I have now come...

Fostering culturally safe care

With empathy, openness and a listening ear, pharmacists can make a big impact in Aboriginal Health Services — for both community members and staff.

International aid and healthcare service provision

How can pharmacists get involved in international aid and healthcare service provision overseas? Working as a pharmacist in overseas development can be stressful –...